Data Dictionary: Pancreatic cancer - DPCA: Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
This is a summary of the variables available in the database. You can download the complete data dictionary. [[https://support.mrdm.com/nl/downloads/documenten/ Click here to learn more]. | This is a summary of the variables available in the database. You can download the complete data dictionary. [[https://support.mrdm.com/nl/downloads/documenten/ Click here to learn more]. | ||
Comorbidities | '''Comorbidities''' | ||
Patient Identification and Treatment Timeline | '''Patient Identification and Treatment Timeline''' | ||
* Treatment start date | * Treatment start date | ||
* Reason for registration | * Reason for registration | ||
| Line 11: | Line 11: | ||
Patient Physical and Performance Metrics | '''Patient Physical and Performance Metrics''' | ||
* Height in cm | * Height in cm | ||
* Preoperative weight in kg | * Preoperative weight in kg | ||
| Line 18: | Line 18: | ||
Laboratory Biomarkers | '''Laboratory Biomarkers''' | ||
* Bilirubine in µmol/l | * Bilirubine in µmol/l | ||
* Hemoglobine in mmol/l | * Hemoglobine in mmol/l | ||
| Line 27: | Line 27: | ||
Imaging and Diagnostic Procedures | '''Imaging and Diagnostic Procedures''' | ||
* CT, MRI, or MRCP performed | * CT, MRI, or MRCP performed | ||
* Date of the last preoperative imaging | * Date of the last preoperative imaging | ||
| Line 35: | Line 35: | ||
Histology and Cytology | '''Histology and Cytology''' | ||
* Preoperative PA number | * Preoperative PA number | ||
* Method and date of obtaining the first positive cytology or histology | * Method and date of obtaining the first positive cytology or histology | ||
| Line 41: | Line 41: | ||
Multidisciplinary Team Consultations and Decisions | '''Multidisciplinary Team Consultations and Decisions''' | ||
* Date of the last MDT (Multidisciplinary Team) discussion before treatment | * Date of the last MDT (Multidisciplinary Team) discussion before treatment | ||
* Working diagnosis and eligibility for surgical exploration | * Working diagnosis and eligibility for surgical exploration | ||
Treatment and Surgery Details | '''Treatment and Surgery Details''' | ||
* Neo-adjuvant/induction treatment type and start date | * Neo-adjuvant/induction treatment type and start date | ||
* Operative details including ASA score, type of resection, and operative complications | * Operative details including ASA score, type of resection, and operative complications | ||
| Line 52: | Line 52: | ||
Postoperative Management and Follow-Up | '''Postoperative Management and Follow-Up''' | ||
* Palliative treatments including chemotherapy and radiotherapy | * Palliative treatments including chemotherapy and radiotherapy | ||
* Date of discharge and any readmissions within 30 days | * Date of discharge and any readmissions within 30 days | ||
* Adjuvant therapy details and participation in oncological trials | * Adjuvant therapy details and participation in oncological trials | ||
Revision as of 21:27, 8 May 2024
Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.
This is a summary of the variables available in the database. You can download the complete data dictionary. [Click here to learn more.
Comorbidities
Patient Identification and Treatment Timeline
- Treatment start date
- Reason for registration
- Hospital patient number
Patient Physical and Performance Metrics
- Height in cm
- Preoperative weight in kg
- Weight loss in kg and period in weeks
- ECOG performance status (Eastern Cooperative Oncology Group)
Laboratory Biomarkers
- Bilirubine in µmol/l
- Hemoglobine in mmol/l
- Albumine in g/l
- IgG4 in g/l
- Carcinoembryonic antigen (CEA) in µg/l
- CA19.9 in kU/l (Note: Last CA19.9 before the start of neoadjuvant treatment or surgery)
Imaging and Diagnostic Procedures
- CT, MRI, or MRCP performed
- Date of the last preoperative imaging
- Presence of a tumor in the pancreas or periampullary on CT or MRI
- Cystic features suggestive of malignancy
- Involvement of vessels and other structures on imaging
Histology and Cytology
- Preoperative PA number
- Method and date of obtaining the first positive cytology or histology
- Histological and cytological diagnoses
Multidisciplinary Team Consultations and Decisions
- Date of the last MDT (Multidisciplinary Team) discussion before treatment
- Working diagnosis and eligibility for surgical exploration
Treatment and Surgery Details
- Neo-adjuvant/induction treatment type and start date
- Operative details including ASA score, type of resection, and operative complications
- Postoperative pathology including tumor origin, size, and grade
Postoperative Management and Follow-Up
- Palliative treatments including chemotherapy and radiotherapy
- Date of discharge and any readmissions within 30 days
- Adjuvant therapy details and participation in oncological trials
